Cargando…
OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065938/ http://dx.doi.org/10.1016/S1590-8658(22)00357-7 |
_version_ | 1784699698580291584 |
---|---|
author | Guarino, M. Esposito, I. Portella, G. Cossiga, V. Loperto, I. Pignata, L. Tortora, R. Attanasio, M.R. Cennamo, M. Capasso, M. Terracciano, D. Cutolo, F.M. Lanza, A.G. Lieto, R. Di Somma, S. Picciotto, F.P. Morisco, F. |
author_facet | Guarino, M. Esposito, I. Portella, G. Cossiga, V. Loperto, I. Pignata, L. Tortora, R. Attanasio, M.R. Cennamo, M. Capasso, M. Terracciano, D. Cutolo, F.M. Lanza, A.G. Lieto, R. Di Somma, S. Picciotto, F.P. Morisco, F. |
author_sort | Guarino, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9065938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90659382022-05-04 OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS Guarino, M. Esposito, I. Portella, G. Cossiga, V. Loperto, I. Pignata, L. Tortora, R. Attanasio, M.R. Cennamo, M. Capasso, M. Terracciano, D. Cutolo, F.M. Lanza, A.G. Lieto, R. Di Somma, S. Picciotto, F.P. Morisco, F. Dig Liver Dis Oral Communications Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-05 2022-05-04 /pmc/articles/PMC9065938/ http://dx.doi.org/10.1016/S1590-8658(22)00357-7 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Oral Communications Guarino, M. Esposito, I. Portella, G. Cossiga, V. Loperto, I. Pignata, L. Tortora, R. Attanasio, M.R. Cennamo, M. Capasso, M. Terracciano, D. Cutolo, F.M. Lanza, A.G. Lieto, R. Di Somma, S. Picciotto, F.P. Morisco, F. OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title | OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title_full | OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title_fullStr | OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title_full_unstemmed | OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title_short | OC.15.2 HUMORAL RESPONSE TO 2-DOSE BNT162B2 MRNA VACCINE FOR COVID-19 IN LIVER TRANSPLANT RECIPIENTS |
title_sort | oc.15.2 humoral response to 2-dose bnt162b2 mrna vaccine for covid-19 in liver transplant recipients |
topic | Oral Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065938/ http://dx.doi.org/10.1016/S1590-8658(22)00357-7 |
work_keys_str_mv | AT guarinom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT espositoi oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT portellag oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT cossigav oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT lopertoi oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT pignatal oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT tortorar oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT attanasiomr oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT cennamom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT capassom oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT terraccianod oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT cutolofm oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT lanzaag oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT lietor oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT disommas oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT picciottofp oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients AT moriscof oc152humoralresponseto2dosebnt162b2mrnavaccineforcovid19inlivertransplantrecipients |